Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07826637) titled 'Study of the Hemorai Vysio Wearable Device for Monitoring Changes Related to Blood Loss in Patients During and After Surgery' on Sept. 14.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Device Feasibility. Masking: None (Open Label).
Primary Sponsor: Hemorai Inc
Condition:
Blood Loss, Surgical
Postoperative Hemorrhage
Intervention:
Device: Wearable optical hemodynamic monitoring device
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 15, 2026
Target Sample Size: 80
Countries of Recruitment:
United S...